Australia’s active hospital-based surveillance for severe childhood disease
PAEDS continues to contribute important paediatric data to national influenza surveillance in collaboration with FluCAN and with the support of a NHMRC partnership grant. After a year of record high influenza activity in 2017, PAEDS has remained well placed to capture hospitalisations, with all seven sites engaged in surveillance for 2018 and 2019.
In 2018, most state and territories committed funding to allow all children and infants aged 6 months to less than 5 years to be vaccinated. Influenza vaccines are adjusted each year to provide optimal coverage against circulating influenza strains, so ongoing surveillance is critical to understanding disease burden and vaccine efficacy and evaluating vaccination program strategies. Clinical epidemiology and vaccine effectiveness of paediatric influenza hospitalisations are analysed each year with FluCAN data; latest results will be available soon. Further analysis is underway to describe hospitalisations among infants under 6 months of age and determine effectiveness of maternal vaccination over several years.
PAEDS receives fundingfrom the Australian government
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2019 PAEDS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.